H-2 class I histocompatibility antigen, K locus (H-2K)

MHC class I H-2K (H-2K) is a key protein in the mouse major histocompatibility complex (MHC), serving as the murine functional equivalent of human HLA-A, B, and C molecules. It is a type I transmembrane glycoprotein that non-covalently associates with beta-2 microglobulin to form a complex capable of binding and presenting 8-10 amino acid endogenous peptides to CD8+ cytotoxic T lymphocytes (CTLs). This interaction is fundamental to the adaptive immune response, allowing for the detection and destruction of cells harboring intracellular pathogens or malignant mutations. Beyond its classical role in immunity, H-2K acts as an inhibitory ligand for natural killer (NK) cells to maintain self-tolerance and has non-canonical functions in the brain, including the regulation of synaptic density and neural progenitor cell proliferation. In therapeutic contexts, H-2K is targeted by experimental vaccines, TCR-like antibodies, and blocking peptides designed to either augment immune responses against cancer or suppress pathogenic T cell activation in autoimmune and inflammatory diseases such as metabolic dysfunction-associated steatohepatitis (MASH) and myositis.

Other names

H2-K1H-2KH2-KK-fHistocompatibility 2, K1, K regionMHC class I H2-KH-2K(B)H-2K(D)H-2K(K)

Competitive inhibition of peptide binding to the MHC groove; Blocking of the TCR/MHC interaction to prevent T cell activation; Antibody-mediated depletion of antigen-presenting cells; Stabilization of MHC molecules to enhance peptide presentation and vaccine efficacy.